Fortrea Holdings Inc (FTRE) Gross Profit Margin starting from the third quarter 2026 to third quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Fortrea Holdings Inc   (NASDAQ: FTRE)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Fortrea Holdings Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



FTRE Gross Profit Margin (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Revenue Change -1.4 %
Seq. Revenue Change 1.96 %
Revenue In Millions $691.50
Gross Profit Margin 20.17 %
Gross Profit Margin Total Ranking # 2944
Gross Profit In Millions $139.50
Y / Y Gross Profit Change 13.69 %
Seq. Gross Profit Change 0.22 %


Commenting Third Quarter 2026 Gross Profit Margin
Fortrea Holdings Inc has managed to improve its Revenue sequentially to $691.50 millions by 1.96 % faster than Gross Profit increase of 0.22 % to $139.50 millions, this led to contraction in Gross Profit Margin to 20.17 %, but the Fortrea Holdings Inc III. Quarter Gross Profit Margin remained above company average rate of 19.92%.


Observing third quarter 2026 results within Medical Laboratories industry 25 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 2944, from total ranking in the previous quarter at 3301.
Learn about Gross Margin
FTRE's Gross Profit Margin third quarter 2026 Company Ranking
Within: No.
Medical Laboratories Industry # 26
Healthcare Sector # 416
Overall # 2920

Gross Profit Margin Statistics
High Average Low
31.94 % 19.92 % 16.3 %
(Dec 31 2023)   (Mar 31 2024)




Other Gross Profit Margin Profitability Ratios
FTRE's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
FTRE's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for FTRE's Competitors
Gross Profit Margin Profit Margin for Fortrea Holdings Inc 's Suppliers
Gross Profit Margin Profit Margin for FTRE's Customers

You may also want to know
FTRE's Annual Growth Rates FTRE's Profitability Ratios FTRE's Asset Turnover Ratio FTRE's Dividend Growth
FTRE's Roe FTRE's Valuation Ratios FTRE's Financial Strength Ratios FTRE's Gross Profit Growth
FTRE's Roa FTRE's Inventory Turnover Ratio FTRE's Growth Rates FTRE's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2026, within Medical Laboratories Industry Gross Profit MarginSep 30 2026 MRQ Gross ProfitSep 30 2026 MRQ Revenue
Caredx Inc   44.61 %$ 62.174  Millions$ 139.362  Millions
Aclarion Inc   43.86 %$ 0.015  Millions$ 0.034  Millions
Ge Healthcare Technologies Inc   40.34 %$ 2,224.000  Millions$ 5,513.000  Millions
Fulgent Genetics Inc   35.33 %$ 31.947  Millions$ 90.412  Millions
Iqvia Holdings Inc   33.83 %$ 1,498.000  Millions$ 4,428.000  Millions
Quest Diagnostics Inc  33.65 %$ 1,042.000  Millions$ 3,097.000  Millions
Medpace Holdings Inc   31.27 %$ 223.885  Millions$ 716.000  Millions
Labcorp Holdings Inc   29.08 %$ 1,108.100  Millions$ 3,810.000  Millions
Personalis Inc   25.67 %$ 6.570  Millions$ 25.596  Millions
Fortrea Holdings Inc   20.17 %$ 139.500  Millions$ 691.500  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.